about
Generation and characterisation of Rhd and Rhag null miceThe chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging.Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter.A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress.Reversing resistance to vascular-disrupting agents by blocking late mobilization of circulating endothelial progenitor cells.RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis.Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143).A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome.Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV).In vitro infection of bone marrow-adherent cells by human immunodeficiency virus type 1 (HIV-1) does not alter their ability to support hematopoiesis.Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization.Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells.Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4-/- chimeric mice.Specific modulation of surface receptors in J.774 macrophages by anchorage.Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokinesSuccessful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− miceLe monoxyde d’azote dans l’hématopoïèseProplatelet formation is regulated by the Rho/ROCK pathwayIdentification of human T-lymphoid progenitor cells in CD34+CD38low and CD34+CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ culturesThe iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell linesDifferentiation of U-937 human monocyte-like cell line by 1α,25-dihydroxyvitamin D3 or by retinoic acidIn vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis
P50
Q28513073-94DE31FB-23A4-4A12-9CC0-D93C858FA1B7Q33302115-D9825387-02D2-45BD-A4B1-7C5A6DDBBCF5Q33370471-37F97EF3-8552-4CF3-B4FF-1EDC51D735EDQ33422883-B44B1AF3-EF6D-4B26-A199-2222B7CDE581Q34684316-8818D4DA-2D33-4F3A-A9A4-975E474AF2A6Q35944308-957D8E22-D526-4044-A859-D4F78A4F3069Q36256357-AE8B6A6C-23A6-404E-94D3-A040C160608CQ36347213-F6B11078-5993-4542-9696-AF86FD111EB3Q37191875-49ECDC6D-62D6-4950-84C8-34E25B5E5EF6Q37292779-A3A7D7E0-2B37-4B2E-8640-568CD0D8200DQ38721023-AAE1EA45-01BF-433C-8BFD-9A25554C6185Q38736625-D359273E-A3BB-4C07-8F5F-EDB30AA6ABCCQ39149556-F5D9C57D-5249-4804-A439-E6BA50367F64Q39154440-28FE5CFE-1C5D-46F2-851D-43CF4768799EQ39347815-E4B10708-15A5-4D4A-B82B-4647A11D83B2Q40401576-C8E5CCC8-BD92-4CAA-A722-6858898F5263Q40835181-CB66FB43-634B-4193-9A6C-84FF26016378Q41260777-5EB94C1D-224C-4F6F-85B5-56C0232883B6Q44429187-B7A1F4C8-29BB-4A57-89F5-EF7A00E6E5AFQ45785777-4C2D9D6A-6963-46FB-88BB-1CA622D71D40Q45790627-F79F41DB-3906-4BE8-9832-98B098D97A5AQ47128179-972CF315-8696-4472-B8FB-C9E68D871C44Q50786871-9D406FA2-49E4-46CE-8F95-7AA1FBB6B352Q53743494-404EF381-53F7-45EC-B77A-B02F71EEDD3AQ54694677-0CEDBDD3-B8D4-427A-9713-B1F4D5A76BE0Q58125348-5D53F51A-EDB0-40D7-B46B-DDD8A8478BF6Q58125472-1AA90C42-7162-41EE-BE15-C9AAB4BBB26FQ58125500-E109FB47-AB85-4EA1-8790-7A00DDA69F68Q58125582-96F6CC5E-E59F-499A-9C30-D8A0112D38A0Q58125714-FC0A4516-5F4F-41B1-A5DD-8ED4EB522E36Q58125914-6941DA43-53F0-4B04-8994-CDF71E52AD02Q58125926-92F55267-94BB-4572-A0CB-7B5EED6EEBFDQ64103896-6B3C0EE0-7E89-48A1-AEA6-9BD4BE811854
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fawzia Louache
@ast
Fawzia Louache
@en
Fawzia Louache
@es
Fawzia Louache
@nl
Fawzia Louache
@sl
type
label
Fawzia Louache
@ast
Fawzia Louache
@en
Fawzia Louache
@es
Fawzia Louache
@nl
Fawzia Louache
@sl
prefLabel
Fawzia Louache
@ast
Fawzia Louache
@en
Fawzia Louache
@es
Fawzia Louache
@nl
Fawzia Louache
@sl
P106
P31
P496
0000-0002-4247-5421